T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.7B |
| 2 |
Verizon
VZ
|
+$1.36B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 4 |
US Bancorp
USB
|
+$1.29B |
| 5 |
Merck
MRK
|
+$1.23B |
Top Sells
| 1 |
Amazon
AMZN
|
+$5.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.57B |
| 3 |
Tesla
TSLA
|
+$3.67B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.43B |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.69% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Sarepta Therapeutics
SRPT
$1.85B
| $108M | 0.02% |
836,693
-382,178
| -31% | -$49.5M |
|
477
KT
KT
$9.64B
| $108M | 0.02% |
8,016,938
+162,157
| +2% | +$2.19M |
|
478
EastGroup Properties
EGP
$8.8B
| $107M | 0.02% |
719,386
+3,142
| +0.4% | +$465K |
|
479
Exelixis
EXEL
$10.3B
| $106M | 0.02% |
6,627,890
-1,395,152
| -17% | -$22.4M |
|
480
Bank of New York Mellon
BK
$73.9B
| $106M | 0.02% |
2,331,190
-896,271
| -28% | -$40.8M |
|
481
Paychex
PAYX
$48.3B
| $106M | 0.02% |
916,473
+40,488
| +5% | +$4.68M |
|
482
Airbnb
ABNB
$75.8B
| $105M | 0.02% |
1,231,028
-144,505
| -11% | -$12.4M |
|
483
Assurant
AIZ
$10.7B
| $105M | 0.02% |
839,929
-72,473
| -8% | -$9.06M |
|
484
Martin Marietta Materials
MLM
$37B
| $105M | 0.02% |
309,521
-11,691
| -4% | -$3.95M |
|
|
COUP
485
DELISTED
Coupa Software Incorporated
COUP
| $104M | 0.02% |
1,312,868
-932,988
| -42% | -$73.9M |
|
|
ISEE
486
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $104M | 0.02% |
4,843,659
+1,397,305
| +41% | +$29.9M |
|
487
Fair Isaac
FICO
$37.1B
| $102M | 0.02% |
171,038
-14,684
| -8% | -$8.79M |
|
488
Denali Therapeutics
DNLI
$2.25B
| $101M | 0.02% |
3,648,888
+170,520
| +5% | +$4.74M |
|
|
ONC
489
BeOne Medicines Ltd. American Depositary Shares
ONC
$38.6B
| $101M | 0.02% |
461,093
+13,676
| +3% | +$3.01M |
|
490
Gartner
IT
$18.7B
| $101M | 0.02% |
300,224
-20,991
| -7% | -$7.06M |
|
491
Affirm
AFRM
$28.8B
| $101M | 0.02% |
10,434,854
-113,695
| -1% | -$1.1M |
|
|
DICE
492
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $100M | 0.02% |
3,219,960
+666,503
| +26% | +$20.8M |
|
493
Vornado Realty Trust
VNO
$7.66B
| $100M | 0.02% |
4,809,659
-22,860
| -0.5% | -$476K |
|
494
Apple Hospitality REIT
APLE
$2.99B
| $100M | 0.02% |
6,336,143
-1,329,145
| -17% | -$21M |
|
495
Valero Energy
VLO
$50.3B
| $99.9M | 0.02% |
787,100
-100,478
| -11% | -$12.7M |
|
496
Lattice Semiconductor
LSCC
$9.05B
| $99.4M | 0.02% |
1,532,501
-46,985
| -3% | -$3.05M |
|
497
Banco Santander Chile
BSAC
$12.1B
| $99.3M | 0.02% |
6,267,896
+5,888,617
| +1,553% | +$93.3M |
|
498
Royalty Pharma
RPRX
$15.8B
| $99M | 0.02% |
2,504,532
+161,722
| +7% | +$6.39M |
|
499
AngloGold Ashanti
AU
$31.3B
| $98.6M | 0.02% |
5,077,773
-4,983,538
| -50% | -$96.8M |
|
|
ABCM
500
DELISTED
Abcam plc American Depositary Shares
ABCM
| $98.2M | 0.02% |
+6,313,950
| New | +$98.2M |
|